Tag

CAR-T cell therapy

Dr. Ulrike Herbrand and Dr. Sascha Karassek, Charles River Laboratories

Editorial ArticleDrug Discovery & Development

Matrix approach enhances potency assay development for ATMPs

Scientists at Charles River Laboratories share top tips for overcoming the challenges of designing a potency assay development strategy for advanced therapy medicinal products

29 Aug 2024

Expert InsightsSeparations

9 upcoming webinars to optimize your scientific processes

23 Jun 2022

Editorial ArticleDrug discovery > Lead Discovery

Virtual Biopharmaceutical Summit 2020: Full meeting agenda

27 Nov 2020

Editorial ArticleLife Sciences

Innovating Cell Biology Technology to Improve Human Health

12 Feb 2019

Webinars

Rewiring the metabolism of CAR-T cells

Dec 10, 2024

In process assessment of critical process parameters impacting CAR T-cell potency, metabolic fitness and phenotype

Jan 9, 2025

Translatable efficacy & safety testing of mAb, bispecific, & CAR T therapies

Available on-demand

Editorial Articles

Matrix approach enhances potency assay development for ATMPs

29 Aug 2024

Virtual Biopharmaceutical Summit 2020: Full meeting agenda

27 Nov 2020

Innovating Cell Biology Technology to Improve Human Health

12 Feb 2019

Latest Videos

An in vivo safety and efficacy model for T-cell engagers

11 Sept 2024

Assessing efficacy and safety of CAR T-cell therapies

11 Sept 2024

Updates in translational pharmacology advancing therapeutics

11 Sept 2024